Skip to Navigation Skip to Search Skip to Content
Search All Centers

Michele Nadeem-Baker's Video Blog Update

Published on July 29, 2016

On location in Boston, Patient Power Founder and Host, Andrew Schorr, and Patient Power Correspondent, Michele Nadeem-Baker, discuss the Dana-Farber Cancer Institute FCR+ibrutinib clinical trial in which Michele is participating.  She is very close to achieving MRD negativity and attributes this and her positive outlook for the future to her participation in the clinical trial.  “It kept me alive, and will keep me alive!” exclaims Michele.  

Featuring

You might also like